1189107-22-9 Usage
Description
Ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate is a quinazoline derivative with the molecular formula C12H10ClNO3. It features a chlorine atom and a methoxy group attached to the quinazoline ring, along with an ethyl ester group at the 2-carboxylate position. This chemical compound is known for its potential biological activities and has been studied for its pharmacological properties, such as anti-cancer, anti-inflammatory, and anti-bacterial effects. Its unique structure and properties make it a promising candidate for research in medicinal chemistry and drug development.
Uses
Used in Pharmaceutical Industry:
Ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate is used as a pharmaceutical agent for its potential anti-cancer properties. It has been studied for its ability to target and inhibit the growth of cancer cells, making it a valuable compound in the development of new cancer treatments.
Used in Anti-inflammatory Applications:
Ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate is also used as an anti-inflammatory agent, leveraging its potential to reduce inflammation and alleviate symptoms associated with various inflammatory conditions.
Used in Anti-bacterial Applications:
Ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate is utilized as an anti-bacterial agent, demonstrating effectiveness against certain bacterial strains. This makes it a candidate for the development of new antibiotics to combat bacterial infections.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, this compound serves as a subject of research for understanding its structure-activity relationships and optimizing its pharmacological properties for various therapeutic applications.
Used in Drug Development:
Ethyl 4-chloro-7-methoxyquinazoline-2-carboxylate is employed in drug development processes to create new medications that can address unmet medical needs, particularly in the areas of cancer, inflammation, and bacterial infections.
Check Digit Verification of cas no
The CAS Registry Mumber 1189107-22-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,9,1,0 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1189107-22:
(9*1)+(8*1)+(7*8)+(6*9)+(5*1)+(4*0)+(3*7)+(2*2)+(1*2)=159
159 % 10 = 9
So 1189107-22-9 is a valid CAS Registry Number.
1189107-22-9Relevant articles and documents
JAK KINASE MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF USE THEREOF
-
Page/Page column 115, (2010/09/17)
Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions. (I).
